These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 32413326)

  • 1. Natural Compounds as Pharmaceuticals: The Key Role of Cytochromes P450 Reactivity.
    Di Nardo G; Gilardi G
    Trends Biochem Sci; 2020 Jun; 45(6):511-525. PubMed ID: 32413326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of engineered cytochromes P450 for accelerating drug discovery and development.
    Thomson RES; D'Cunha SA; Hayes MA; Gillam EMJ
    Adv Pharmacol; 2022; 95():195-252. PubMed ID: 35953156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochromes P450 as useful biocatalysts: addressing the limitations.
    O'Reilly E; Köhler V; Flitsch SL; Turner NJ
    Chem Commun (Camb); 2011 Mar; 47(9):2490-501. PubMed ID: 21264369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesizing Chiral Drug Intermediates by Biocatalysis.
    Jiang W; Fang B
    Appl Biochem Biotechnol; 2020 Sep; 192(1):146-179. PubMed ID: 32323141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in the application of P450 based biocatalysts.
    Wei Y; Ang EL; Zhao H
    Curr Opin Chem Biol; 2018 Apr; 43():1-7. PubMed ID: 29100098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytochrome P450 monooxygenases - versatile biocatalysts].
    Wszołek A
    Postepy Biochem; 2022 Dec; 68(4):399-409. PubMed ID: 36649139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of engineered cytochrome P450 mutants as biocatalysts for the synthesis of benzylic and aromatic metabolites of fenamic acid NSAIDs.
    Venkataraman H; Verkade-Vreeker MC; Capoferri L; Geerke DP; Vermeulen NP; Commandeur JN
    Bioorg Med Chem; 2014 Oct; 22(20):5613-20. PubMed ID: 24999003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for development and implementation of biocatalytic P450 processes.
    Lundemo MT; Woodley JM
    Appl Microbiol Biotechnol; 2015 Mar; 99(6):2465-83. PubMed ID: 25652652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric cytochromes P450 engineered by domain swapping and random mutagenesis for producing human metabolites of drugs.
    Kang JY; Ryu SH; Park SH; Cha GS; Kim DH; Kim KH; Hong AW; Ahn T; Pan JG; Joung YH; Kang HS; Yun CH
    Biotechnol Bioeng; 2014 Jul; 111(7):1313-22. PubMed ID: 24474032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochromes P450 in the biocatalytic valorization of lignin.
    Wolf ME; Hinchen DJ; DuBois JL; McGeehan JE; Eltis LD
    Curr Opin Biotechnol; 2022 Feb; 73():43-50. PubMed ID: 34303185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering Plant Cytochrome P450s for Enhanced Synthesis of Natural Products: Past Achievements and Future Perspectives.
    Shang Y; Huang S
    Plant Commun; 2020 Jan; 1(1):100012. PubMed ID: 33404545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450/redox partner fusion enzymes: biotechnological and toxicological prospects.
    McLean KJ; Girvan HM; Munro AW
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):847-63. PubMed ID: 18028029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural modelling of the human drug-metabolizing cytochromes P450.
    Lewis DF; Ito Y; Goldfarb PS
    Curr Med Chem; 2006; 13(22):2645-52. PubMed ID: 17017916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding P450 catalytic reaction space through evolution and engineering.
    McIntosh JA; Farwell CC; Arnold FH
    Curr Opin Chem Biol; 2014 Apr; 19():126-34. PubMed ID: 24658056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the organic toolbox: a guide to integrating biocatalysis in synthesis.
    Clouthier CM; Pelletier JN
    Chem Soc Rev; 2012 Feb; 41(4):1585-605. PubMed ID: 22234546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution of cytochrome P450 enzymes as biocatalysts in drug discovery and development.
    Gillam EM; Hayes MA
    Curr Top Med Chem; 2013; 13(18):2254-80. PubMed ID: 24047135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Directed evolution of cytochrome P450 enzymes for biocatalysis: exploiting the catalytic versatility of enzymes with relaxed substrate specificity.
    Behrendorff JB; Huang W; Gillam EM
    Biochem J; 2015 Apr; 467(1):1-15. PubMed ID: 25793416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-sufficient P450-reductase chimeras for biocatalysis.
    Stout CN; Renata H
    Methods Enzymol; 2023; 693():51-71. PubMed ID: 37977738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation.
    Kumar S
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):115-31. PubMed ID: 20064075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow Biocatalysis: A Challenging Alternative for the Synthesis of APIs and Natural Compounds.
    Santi M; Sancineto L; Nascimento V; Braun Azeredo J; Orozco EVM; Andrade LH; Gröger H; Santi C
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.